These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38087928)

  • 1. Altered Glucagon and GLP-1 Responses to Oral Glucose in Children and Adolescents With Obesity and Insulin Resistance.
    Stinson SE; Fernández de Retana Alzola I; Brünner Hovendal ED; Lund MAV; Fonvig CE; Holm LA; Jonsson AE; Frithioff-Bøjsøe C; Christiansen M; Pedersen O; Ängquist L; Sørensen TIA; Holst JJ; Hartmann B; Holm JC; Hansen T
    J Clin Endocrinol Metab; 2024 May; 109(6):1590-1600. PubMed ID: 38087928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
    Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
    Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits.
    Gjesing AP; Ekstrøm CT; Eiberg H; Urhammer SA; Holst JJ; Pedersen O; Hansen T
    Diabetologia; 2012 May; 55(5):1338-45. PubMed ID: 22349073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.
    Cypryk K; Vilsbøll T; Nadel I; Smyczyńska J; Holst JJ; Lewiński A
    Gynecol Endocrinol; 2007 Jan; 23(1):58-62. PubMed ID: 17484514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fructose Consumption Contributes to Hyperinsulinemia in Adolescents With Obesity Through a GLP-1-Mediated Mechanism.
    Galderisi A; Giannini C; Van Name M; Caprio S
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3481-3490. PubMed ID: 30938760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with autoimmune liver disease have glucose disturbances that mechanistically differ from steatotic liver disease.
    Jensen AH; Ytting H; Werge MP; Rashu EB; Hetland LE; Thing M; Nabilou P; Burisch J; Bojsen-Møller KN; Junker AE; Hobolth L; Mortensen C; Tofteng F; Bendtsen F; Møller S; Vyberg M; Serizawa RR; Gluud LL; Wewer Albrechtsen NJ
    Am J Physiol Gastrointest Liver Physiol; 2024 Jun; 326(6):G736-G746. PubMed ID: 38625142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incretin secretion in obese Korean children and adolescents with newly diagnosed type 2 diabetes.
    Park SH; Jung MH; Cho WK; Park MS; Suh BK
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):72-9. PubMed ID: 25903996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.
    Greenfield JR; Farooqi IS; Keogh JM; Henning E; Habib AM; Blackwood A; Reimann F; Holst JJ; Gribble FM
    Am J Clin Nutr; 2009 Jan; 89(1):106-113. PubMed ID: 19056578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses.
    Engelbrechtsen L; Mahendran Y; Jonsson A; Gjesing AP; Weeke PE; Jørgensen ME; Færch K; Witte DR; Holst JJ; Jørgensen T; Grarup N; Pedersen O; Vestergaard H; Torekov S; Kanters JK; Hansen T
    BMC Genet; 2018 Mar; 19(1):15. PubMed ID: 29548277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
    Manell H; Staaf J; Manukyan L; Kristinsson H; Cen J; Stenlid R; Ciba I; Forslund A; Bergsten P
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1181-9. PubMed ID: 26745255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
    Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
    Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
    Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
    de Jesús Garduno-Garcia J; Gastaldelli A; DeFronzo RA; Lertwattanarak R; Holst JJ; Musi N
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2613-2619. PubMed ID: 29672742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24-h severe energy restriction impairs postprandial glycaemic control in young, lean males.
    Clayton DJ; Biddle J; Maher T; Funnell MP; Sargeant JA; King JA; Hulston CJ; Stensel DJ; James LJ
    Br J Nutr; 2018 Nov; 120(10):1107-1116. PubMed ID: 30401004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of incretins in oral glucose and lipid tolerance tests may be indicative in the diagnosis of metabolic syndrome aggravation.
    Kiec-Klimczak M; Malczewska-Malec M; Razny U; Zdzienicka A; Gruca A; Goralska J; Pach D; Gilis-Januszewska A; Dembinska-Kiec A; Hubalewska-Dydejczyk A
    J Physiol Pharmacol; 2016 Apr; 67(2):217-26. PubMed ID: 27226181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance.
    Zhang F; Tang X; Cao H; Lü Q; Li N; Liu Y; Zhang X; Zhang Y; Cao M; Wan J; An Z; Tong N
    Int J Med Sci; 2012; 9(7):574-81. PubMed ID: 22991496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incretin secretion in humans is under the influence of cannabinoid receptors.
    Chia CW; Carlson OD; Liu DD; González-Mariscal I; Santa-Cruz Calvo S; Egan JM
    Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E359-E366. PubMed ID: 28655715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.
    Vaag AA; Holst JJ; Vølund A; Beck-Nielsen HB
    Eur J Endocrinol; 1996 Oct; 135(4):425-32. PubMed ID: 8921824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.